Pharmacologic Characterization of JNJ-42226314, [1-(4-fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase InhibitorRyan M. Wyatt,Ian Fraser,Natalie Welty,Brian Lord,Michelle Wennerholm,Steven Sutton,Michael K. Ameriks,Christine Dugovic,Sujin Yun,Allison White,Leslie Nguyen,Tatiana Koudriakova,Gaochao Tian,Javier Suarez,Lawrence Szewczuk,William Bonnette,Kay Ahn,Brahma Ghosh,Christopher M. Flores,Peter J. Connolly,Bin Zhu,Mark J. Macielag,Michael R. Brandt,Kristen Chevalier,Sui-Po Zhang,Timothy Lovenberg,Pascal BonaventureJournal of Pharmacology and Experimental Therapeutics（2019）引用 14|浏览46暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
